Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Multiple Electrolytes and Invert Sugar Injection

Approval Number

国药准字H20050494

Company四川美大康佳乐药业有限公司

Registration Date

March 27, 2020

Drug Information

Generic Name

转化糖电解质注射液

Trade Name

海斯维

Brand Name

海斯维

Dosage Form

注射剂(注射液)

Strength

250ml:果糖6.25g与葡萄糖6.25g与乳酸钠0.7004g与氯化钠0.3652g与氯化钾0.4660g与氯化镁0.0714g与磷酸二氢钠0.1875g与亚硫酸氢钠0.1301g。

Drug Type

化学药品

Registration Date

March 27, 2020

Company Information

Applicant Company

Company Name四川美大康佳乐药业有限公司

Manufacturing Company

Company Name四川美大康佳乐药业有限公司

Company Address

成都高新区西部园区西芯大道15号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy